NASDAQ:APLT - Applied Therapeutics News Headlines

$9.54
+0.64 (+7.19 %)
(As of 08/18/2019 02:58 PM ET)
Add
Compare
Today's Range
$8.75
Now: $9.54▼
$9.75
50-Day Range
$8.12
MA: $8.84▼
$9.52
52-Week Range
$7.95
Now: $9.54▼
$11.20
Volume6,800 shs
Average Volume8,959 shs
Market Capitalization$162.66 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Applied Therapeutics (NASDAQ APLT) News Headlines

Source:
DateHeadline
What Percentage Of Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Do Insiders Own?What Percentage Of Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Do Insiders Own?
finance.yahoo.com - August 14 at 10:06 PM
Applied Therapeutics (NASDAQ:APLT) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPSApplied Therapeutics (NASDAQ:APLT) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS
www.americanbankingnews.com - August 13 at 8:20 AM
Applied Therapeutics Reports Second Quarter 2019 Financial ResultsApplied Therapeutics Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 12 at 1:09 PM
Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia StudyApplied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study
finance.yahoo.com - August 8 at 12:56 PM
Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in GalactosemiaApplied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia
finance.yahoo.com - June 24 at 3:18 PM
Applied Therapeutics net loss widens in Q1Applied Therapeutics net loss widens in Q1
seekingalpha.com - June 21 at 10:05 AM
Applied Therapeutics Reports First Quarter 2019 Financial ResultsApplied Therapeutics Reports First Quarter 2019 Financial Results
finance.yahoo.com - June 21 at 10:05 AM
Applied Therapeutics Stock Jumps as Analysts Give It a Bullish WelcomeApplied Therapeutics Stock Jumps as Analysts Give It a Bullish Welcome
finance.yahoo.com - June 10 at 3:17 PM
Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Session at the American Diabetes Association 79th Annual Scientific SessionsApplied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Session at the American Diabetes Association 79th Annual Scientific Sessions
finance.yahoo.com - June 7 at 3:16 PM
Applied Therapeutics AT-007 an orphan drug for GalactosemiaApplied Therapeutics' AT-007 an orphan drug for Galactosemia
seekingalpha.com - May 28 at 3:15 PM
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in GalactosemiaApplied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
finance.yahoo.com - May 28 at 3:15 PM
Robust clinical and preclinical data featured in prominent Late Breaking Science and Basic and Translational Hot Line sessionsRobust clinical and preclinical data featured in prominent Late Breaking Science and Basic and Translational Hot Line sessions
www.globenewswire.com - May 24 at 3:15 PM
Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective AApplied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective A
www.nasdaq.com - May 24 at 3:15 PM
Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor for Treatment of Diabetic CardiomyopathyApplied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor for Treatment of Diabetic Cardiomyopathy
finance.yahoo.com - May 24 at 3:15 PM
Tuesday 5/21 Insider Buying Report: APLT, RESITuesday 5/21 Insider Buying Report: APLT, RESI
www.nasdaq.com - May 22 at 5:23 AM
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: Quantitative Easing
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel